Gilead will try to win approval for what is now GS-1811, while Jounce develops other immunotherapy drugs. JNCE stock is soaring. More
Articles
Bet on the Future of Hydrogen With Bloom Energy Stock
BE stock has long-term growth potential as Bloom Energy pushes the envelope of clean, efficient hydrogen-production technology. More
Sell These 10 Stocks Before the New Year
Today, I have a list of 10 stocks that my Portfolio Grader recently flagged as immediate sells. Take a look below; some of these names might surprise you. More